Literature DB >> 8035173

Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor.

E H Cook1, K E Fletcher, M Wainwright, N Marks, S Y Yan, B L Leventhal.   

Abstract

Previous radioligand binding studies have demonstrated human platelet serotonin2A (5-HT2A) receptor binding sites. Pharmacological similarities between platelet and frontal cortex 5-HT2A receptor binding parameters have been demonstrated. However, it is not clear whether the platelet 5-HT2A receptor primary structure is identical to that of the brain receptor. Three overlapping cDNAs were obtained to span completely the coding region of the 5-HT2A receptor. These clones were sequenced with external and internal primers. The nucleotide sequence of human platelet 5-HT2A cDNA was identical to that reported for the human frontal cortex 5-HT2A receptor, except for nucleotide 102 (T-->C), which has been reported to represent a normal DNA polymorphism that does not alter the amino acid sequence. This finding may have implications in the study of neuropsychiatric disorders for which altered platelet 5-HT2A receptor binding has been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035173     DOI: 10.1046/j.1471-4159.1994.63020465.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway.

Authors:  Wagner Santos Coelho; Mauro Sola-Penna
Journal:  Mol Cell Biochem       Date:  2012-09-26       Impact factor: 3.396

Review 3.  Platelets and depression in cardiovascular disease: A brief review of the current literature.

Authors:  Marlene S Williams
Journal:  World J Psychiatry       Date:  2012-12-22

Review 4.  Brief report: pathophysiology of autism: neurochemistry.

Authors:  E H Cook
Journal:  J Autism Dev Disord       Date:  1996-04

5.  Antiplatelet activity of 3-butyl-6-bromo-1(3H)-isobenzofuranone on rat platelet aggregation.

Authors:  Feifei Ma; Yuan Gao; Hailing Qiao; Xiangjie Hu; Junbiao Chang
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

6.  Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.

Authors:  A Bronowska; Z Chilmonczyk; A Leś; O Edvardsen; R Ostensen; I Sylte
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

7.  Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism.

Authors:  Sarah Cross; Soo-Jeong Kim; Lauren A Weiss; Ryan J Delahanty; James S Sutcliffe; Bennett L Leventhal; Edwin H Cook; Jeremy Veenstra-Vanderweele
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

8.  Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment.

Authors:  Ghanshyam N Pandey; Subhash C Pandey; Xinguo Ren; Yogesh Dwivedi; Philip G Janicak
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

9.  Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Authors:  Lars Wöckel; Florian Daniel Zepf; Sabrina Koch; Anikó-Eva Meyer-Keitel; Martin H Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

10.  Hyperserotonemia in autism: activity of 5HT-associated platelet proteins.

Authors:  Dubravka Hranilović; Zorana Bujas-Petković; Maja Tomicić; Tatjana Bordukalo-Niksić; Sofia Blazević; Lipa Cicin-Sain
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.